Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00013143 · ClinicalTrials.gov registry record · NA

Patient Profiling and Provider Feedback to Reduce Adverse Drug Events

A NA study of Adverse Drug Events, sponsored by US Department of Veterans Affairs.

Completed
Registry status
NA
Development phase
1,200
Enrollment target
1
Study location

NCT00013143 is a NA study of Adverse Drug Events that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 1,200 participants, above the 589-participant average among 6 other Adverse Drug Events trials with a reported enrollment target (104% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00013143, a NA study of Adverse Drug Events, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
NA
Development phase
1,200 participants
Enrollment target
1
Study location

Study Summary

Adverse drug events (ADE) present a unique focus for error reduction. Computerized provider order entry, with embedded clinical decision support, has great promise in reducing medication errors but preventable adverse drug events may still occur despite such systems.

Conditions Studied

Interventions

  • BEHAVIORAL Patient risk profiling (potential ADEs) w/provider feedback

Study Locations (1)

California

  • VA Greater Los Angeles Healthcare System, West Los Angeles, CA - West Los Angeles

Trial Details

FieldValue
Enrollment Target 1,200 participants
Start Date 2001-06
Est. Completion 2003-01
Phase NA

Sponsor

US Department of Veterans Affairs

632 total trials

What the Registry Record Tells You About NCT00013143

The ClinicalTrials.gov registry entry for NCT00013143 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 589-participant average among 6 other Adverse Drug Events trials with a reported enrollment target (104% higher). The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Adverse Drug Events appearing as the primary indexed condition, and to 1 intervention - of which Patient risk profiling (potential ADEs) w/provider feedback is the first listed.

NCT00013143 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00013143 about?

NCT00013143 is a clinical study titled "Patient Profiling and Provider Feedback to Reduce Adverse Drug Events". Adverse drug events (ADE) present a unique focus for error reduction. Computerized provider order entry, with embedded clinical decision support, has great promise in reducing medication errors but preventable adverse drug events may still occur despite such systems.

What is the current status of trial NCT00013143?

This trial is currently completed. It is a NA study. The enrollment target is 1,200 participants. The study started on 2001-06. Estimated completion is 2003-01.

What conditions does trial NCT00013143 study?

This clinical trial studies the following conditions: Adverse Drug Events.

What interventions are being tested in trial NCT00013143?

The interventions under investigation include: Patient risk profiling (potential ADEs) w/provider feedback (BEHAVIORAL).

Who is sponsoring clinical trial NCT00013143?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00013143 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Adverse Drug Events

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.